Streetbeat News

Revenues

KARO

Karooooo reported a 15% year-over-year increase in subscription revenue for Q2 2025, reaching ZAR986 million. Operating profit also rose by 22% to ZAR302 million.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:56 am

BAC

Bank of America reported Q3 2024 earnings of $0.81 per share, surpassing the analyst consensus of $0.78. The company's sales reached $25.49 billion, exceeding expectations of $25.29 billion and marking a 0.68% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:46 am

BABA

JD

NIO

US-listed Chinese stocks are experiencing a decline in share prices following China's September export figures, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:46 am

NAT

Nordic American Tankers (NAT) has signed a 5-year time charter contract with a major energy firm, starting in November 2024. The rate is in the mid-high 30's.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:44 am

PNC

PNC Financial Services Group reported Q3 2024 earnings per share of $3.49, surpassing the analyst estimate of $3.32. The company's sales were $5.432 billion, exceeding the expected $5.389 billion and marking a 3.80% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:37 am

GMAB

Genmab A/S reported $3 billion in DARZALEX sales for Q3 2024, with royalties from these sales continuing to rise. The sales were reported by Johnson & Johnson, with $1.684 billion in the U.S. and $1.332 billion internationally. Genmab receives royalties from these sales under a license agreement with Janssen.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:27 am

JNJ

Johnson & Johnson has updated its 2024 sales guidance to $88.4B–$88.8B, slightly above its previous guidance and close to consensus estimates. The company also provided adjusted operational EPS figures, indicating a slight decrease compared to prior guidance.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:25 am

FBK

FB Financial (NYSE:FBK) reported Q3 2024 earnings per share of $0.86, beating the consensus estimate of $0.80. However, sales were $89.520 million, missing the $128.281 million estimate and showing a decline from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:18 am

MVIS

MicroVision reaffirms its FY24 revenue guidance of $8M-$10M, subject to customer approvals, despite reporting lower preliminary Q3 revenue of $0.15M-$0.2M due to a customer delaying orders. The company maintains its annual cash burn rate between $55-$60 million.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:16 am

IMRN

Immuron reported unaudited sales of its OTC immune supplement, Travelan, totaling AUD$1.5 million for the September 2024 quarter, marking a 13% increase from the previous quarter. Sales in North America saw a significant rise of 48%.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:09 am